OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
Wei Liu, Mohamad‐Gabriel Alameh, June F. Yang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14504-14504
Open Access | Times Cited: 15
Wei Liu, Mohamad‐Gabriel Alameh, June F. Yang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14504-14504
Open Access | Times Cited: 15
Showing 15 citing articles:
Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 186-186
Open Access | Times Cited: 53
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 186-186
Open Access | Times Cited: 53
Universal STING mimic boosts antitumour immunity via preferential activation of tumour control signalling pathways
Ying Wang, Sirui Li, Mengying Hu, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 6, pp. 856-866
Closed Access | Times Cited: 27
Ying Wang, Sirui Li, Mengying Hu, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 6, pp. 856-866
Closed Access | Times Cited: 27
The emerging role of miRNAs in Merkel cell carcinoma pathogenesis: Signaling pathway crosstalk
Nehal I. Rizk, Heba M. Midan, Gouda K. Helal, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154771-154771
Closed Access | Times Cited: 24
Nehal I. Rizk, Heba M. Midan, Gouda K. Helal, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154771-154771
Closed Access | Times Cited: 24
DNA mismatch repair in cancer immunotherapy
Junhong Guan, Guo‐Min Li
NAR Cancer (2023) Vol. 5, Iss. 3
Open Access | Times Cited: 16
Junhong Guan, Guo‐Min Li
NAR Cancer (2023) Vol. 5, Iss. 3
Open Access | Times Cited: 16
Sniping Cancer Stem Cells with Nanomaterials
Wen-Da Wang, Yanyu Guo, Zhonglu Yang, et al.
ACS Nano (2023) Vol. 17, Iss. 23, pp. 23262-23298
Closed Access | Times Cited: 12
Wen-Da Wang, Yanyu Guo, Zhonglu Yang, et al.
ACS Nano (2023) Vol. 17, Iss. 23, pp. 23262-23298
Closed Access | Times Cited: 12
Nanomedicines harnessing cGAS-STING pathway: sparking immune revitalization to transform ‘cold’ tumors into ‘hot’ tumors
Xiaohong Ying, Qiaohui Chen, Yongqi Yang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Xiaohong Ying, Qiaohui Chen, Yongqi Yang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
mRNA vaccine in gastrointestinal tumors: Immunomodulatory effects and immunotherapy
Ao Zhang, Qingming Ji, Xia Sheng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115361-115361
Open Access | Times Cited: 9
Ao Zhang, Qingming Ji, Xia Sheng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115361-115361
Open Access | Times Cited: 9
RNA-encapsulating lipid nanoparticles in cancer immunotherapy: From pre-clinical studies to clinical trials
Tiffaney Hsia, Yunching Chen
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 197, pp. 114234-114234
Closed Access | Times Cited: 2
Tiffaney Hsia, Yunching Chen
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 197, pp. 114234-114234
Closed Access | Times Cited: 2
Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapy
Yan Tang, Wei Liu, Siddhant Kadu, et al.
Blood (2023) Vol. 143, Iss. 2, pp. 139-151
Open Access | Times Cited: 6
Yan Tang, Wei Liu, Siddhant Kadu, et al.
Blood (2023) Vol. 143, Iss. 2, pp. 139-151
Open Access | Times Cited: 6
Potentiating the Systemic Immunity by Bacteria‐Delivered Sting Activation in a Tumor Microenvironment
Wenfei Chen, Yining Zhu, Jiahao Chen, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 52
Closed Access | Times Cited: 4
Wenfei Chen, Yining Zhu, Jiahao Chen, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 52
Closed Access | Times Cited: 4
Merkel cell polyomavirus protein ALTO modulates TBK1 activity to support persistent infection
Ranran Wang, Taylor E. Senay, Tiana T. Luo, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 7, pp. e1012170-e1012170
Open Access | Times Cited: 1
Ranran Wang, Taylor E. Senay, Tiana T. Luo, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 7, pp. e1012170-e1012170
Open Access | Times Cited: 1
Merkel cell polyomavirus protein ALTO modulates TBK1 activity to support persistent infection
Ranran Wang, Taylor E. Senay, Tiana T. Luo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Ranran Wang, Taylor E. Senay, Tiana T. Luo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Long ssRNA undergoes continuous compaction in the presence of polyvalent cations
Ana L. Durán-Meza, Liya Oster, Richard Sportsman, et al.
Biophysical Journal (2023) Vol. 122, Iss. 17, pp. 3469-3475
Open Access | Times Cited: 1
Ana L. Durán-Meza, Liya Oster, Richard Sportsman, et al.
Biophysical Journal (2023) Vol. 122, Iss. 17, pp. 3469-3475
Open Access | Times Cited: 1
Modulation of Skin Cancer by the Stimulator of Interferon Genes
Max Oscherwitz, Victoria Jiminez, Hanna Terhaar, et al.
Genes (2023) Vol. 14, Iss. 9, pp. 1794-1794
Open Access | Times Cited: 1
Max Oscherwitz, Victoria Jiminez, Hanna Terhaar, et al.
Genes (2023) Vol. 14, Iss. 9, pp. 1794-1794
Open Access | Times Cited: 1
Lipid Nanoparticle (LNP) Delivery Vector-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
(2023)
Open Access | Times Cited: 1
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
(2023)
Open Access | Times Cited: 1
